192 related articles for article (PubMed ID: 3243910)
1. Improved high-performance liquid chromatographic analysis with double detection system for L-dopa, its metabolites and carbidopa in plasma of parkinsonian patients under L-dopa therapy.
Betto P; Ricciarello G; Giambenedetti M; Lucarelli C; Ruggeri S; Stocchi F
J Chromatogr; 1988 Dec; 459():341-9. PubMed ID: 3243910
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous measurement of L-dopa, its metabolites and carbidopa in plasma of parkinsonian patients by improved sample pretreatment and high-performance liquid chromatographic determination.
Lucarelli C; Betto P; Ricciarello G; Giambenedetti M; Corradini C; Stocchi F; Belliardo F
J Chromatogr; 1990 Jul; 511():167-76. PubMed ID: 2211908
[TBL] [Abstract][Full Text] [Related]
3. Automated determination of levodopa and carbidopa in plasma by high-performance liquid chromatography-electrochemical detection using an on-line flow injection analysis sample pretreatment unit.
Tolokán A; Klebovich I; Balogh-Nemes K; Horvai G
J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):201-7. PubMed ID: 9367209
[TBL] [Abstract][Full Text] [Related]
4. Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients.
Dethy S; Laute MA; Van Blercom N; Damhaut P; Goldman S; Hildebrand J
Clin Chem; 1997 May; 43(5):740-4. PubMed ID: 9166225
[TBL] [Abstract][Full Text] [Related]
5. A new HILIC-MS/MS method for the simultaneous analysis of carbidopa, levodopa, and its metabolites in human plasma.
Vilhena Rde O; Pontes FL; Marson BM; Ribeiro RP; de Carvalho KA; Cardoso MA; Pontarolo R
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 967():41-9. PubMed ID: 25063927
[TBL] [Abstract][Full Text] [Related]
6. Effect of supplemental carbidopa on bioavailability of L-dopa.
Cedarbaum JM; Kutt H; Dhar AK; Watkins S; McDowell FH
Clin Neuropharmacol; 1986; 9(2):153-9. PubMed ID: 3085927
[TBL] [Abstract][Full Text] [Related]
7. Measuring L-dopa in plasma and urine to monitor therapy of elderly patients with Parkinson disease treated with L-dopa and a dopa decarboxylase inhibitor.
Dutton J; Copeland LG; Playfer JR; Roberts NB
Clin Chem; 1993 Apr; 39(4):629-34. PubMed ID: 8472357
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous high-performance liquid chromatographic analysis of carbidopa, levodopa and 3-O-methyldopa in plasma and carbidopa, levodopa and dopamine in urine using electrochemical detection.
Titus DC; August TF; Yeh KC; Eisenhandler R; Bayne WF; Musson DG
J Chromatogr; 1990 Dec; 534():87-100. PubMed ID: 2094725
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection.
Blandini F; Martignoni E; Pacchetti C; Desideri S; Rivellini D; Nappi G
J Chromatogr B Biomed Sci Appl; 1997 Oct; 700(1-2):278-82. PubMed ID: 9390741
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous estimation of levodopa, carbidopa and 3-oxymethyldopa in rat plasma using HPLC-ECD.
Raut PP; Charde SY; Bishnoi P
Biomed Chromatogr; 2016 Oct; 30(10):1696-700. PubMed ID: 26910491
[TBL] [Abstract][Full Text] [Related]
11. Determination of tetrahydropapaveroline in the urine of parkinsonian patients receiving L-dopa-carbidopa (Sinemet) therapy by high-performance liquid chromatography.
Cashaw JL
J Chromatogr; 1993 Apr; 613(2):267-73. PubMed ID: 8491812
[TBL] [Abstract][Full Text] [Related]
12. [The effect of controlled release of DOPA and carbidopa on clinical response and plasma pharmacokinetics of DOPA in parkinsonian patients].
García de Yébenes J; Mateo D; Pino MA; Cordero M; Pastor M; Chacón J; Morales B; Sánchez V; Mena MA; Giménez Roldán S
Neurologia; 1997 Apr; 12(4):145-56. PubMed ID: 9235023
[TBL] [Abstract][Full Text] [Related]
13. Determination of L-dopa, carbidopa, 3-O-methyldopa and entacapone in human plasma by HPLC-ED.
Bugamelli F; Marcheselli C; Barba E; Raggi MA
J Pharm Biomed Anal; 2011 Feb; 54(3):562-7. PubMed ID: 21035976
[TBL] [Abstract][Full Text] [Related]
14. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
Rose S; Jenner P; Marsden CD
Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
[TBL] [Abstract][Full Text] [Related]
15. Determination of levodopa by chromatography-based methods in biological samples: a review.
Jiang R; Yang J; Mei S; Zhao Z
Anal Sci; 2022 Aug; 38(8):1009-1017. PubMed ID: 35715690
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous assay of 3,4-dihydroxyphenylalanine, catecholamines and O-methylated metabolites in human plasma using high-performance liquid chromatography.
Ishimitsu T; Hirose S
J Chromatogr; 1985 Feb; 337(2):239-48. PubMed ID: 3921559
[TBL] [Abstract][Full Text] [Related]
17. Treatment of idiopathic parkinsonism with L-dopa in the absence and presence of decarboxylase inhibitors: effects on plasma levels of L-dopa, dopa decarboxylase, catecholamines and 3-O-methyl-dopa.
Boomsma F; Meerwaldt JD; Man in't Veld AJ; Hovestadt A; Schalekamp MA
J Neurol; 1989 May; 236(4):223-30. PubMed ID: 2760634
[TBL] [Abstract][Full Text] [Related]
18. Plasma DOPA and growth hormone in parkinsonism: oscillations in symptoms.
Papavasiliou PS; McDowell FH; Wang YY; Rosal V; Miller ST
Neurology; 1979 Feb; 29(2):194-200. PubMed ID: 571063
[TBL] [Abstract][Full Text] [Related]
19. Does O-methyl-dopa play a role in levodopa-induced dyskinesias?
Feuerstein C; Tanche M; Serre F; Gavend M; Pellat J; Perret J
Acta Neurol Scand; 1977 Jul; 56(1):79-82. PubMed ID: 878846
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of L-dopa and 3-O-methyldopa in human serum by high-performance liquid chromatography.
Beers MF; Stern M; Hurtig H; Melvin G; Scarpa A
J Chromatogr; 1984 Dec; 336(2):380-4. PubMed ID: 6442301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
